Valdecoxib

This classification denotes a cyclooxygenase inhibitor, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 2919279Q3W. European Medicines Agency schedules Valdecoxib in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05065MIG. Valdecoxib generally arises in the molecular formula C16H14N2O3S. The term VALDECOXIB is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 13 no. 3, 1999, list 42.) Most nations schedule valdecoxib under HS 29350090 and SITC 51580. As of Q4 2014, VALDECOXIB remains the US FDA Preferred Term for this commodity. Valdecoxib bears US NLM identifiers UMLS ID C0913246 and NCI Concept Code C1869. SMILES: S(=O)(=O)(N)C1CCC(C2C(NOC2C)C2CCCCC2)CC1.